REGN logo

REGN Net Income

Annual Net Income:

$4.41B+$459.00M(+11.61%)
December 31, 2024

Summary

  • As of today (October 8, 2025), REGN annual net profit is $4.41 billion, with the most recent change of +$459.00 million (+11.61%) on December 31, 2024.
  • During the last 3 years, REGN annual net income has fallen by -$3.66 billion (-45.36%).
  • REGN annual net income is now -45.36% below its all-time high of $8.08 billion, reached on December 31, 2021.

Performance

REGN Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNincome statement metrics

Quarterly Net Income:

$1.39B+$582.90M(+72.08%)
June 30, 2025

Summary

  • As of today (October 8, 2025), REGN quarterly net profit is $1.39 billion, with the most recent change of +$582.90 million (+72.08%) on June 30, 2025.
  • Over the past year, REGN quarterly net income has dropped by -$40.70 million (-2.84%).
  • REGN quarterly net income is now -55.09% below its all-time high of $3.10 billion, reached on June 30, 2021.

Performance

REGN Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNincome statement metrics

TTM Net Income:

$4.46B-$40.70M(-0.90%)
June 30, 2025

Summary

  • As of today (October 8, 2025), REGN TTM net profit is $4.46 billion, with the most recent change of -$40.70 million (-0.90%) on June 30, 2025.
  • Over the past year, REGN TTM net income has increased by +$136.90 million (+3.17%).
  • REGN TTM net income is now -44.79% below its all-time high of $8.08 billion, reached on December 31, 2021.

Performance

REGN TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

REGN Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+11.6%-2.8%+3.2%
3Y3 Years-45.4%+63.3%-21.6%
5Y5 Years+108.5%+55.1%+41.3%

REGN Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-45.4%+11.6%-2.8%+92.7%-17.0%+15.6%
5Y5-Year-45.4%+108.5%-55.1%+92.7%-44.8%+41.3%
All-TimeAll-Time-45.4%+2089.8%-55.1%+2326.4%-44.8%+2110.6%

REGN Net Income History

DateAnnualQuarterlyTTM
Jun 2025
-
$1.39B(+72.1%)
$4.46B(-0.9%)
Mar 2025
-
$808.70M(-11.9%)
$4.50B(+2.0%)
Dec 2024
$4.41B(+11.6%)
$917.70M(-31.5%)
$4.41B(-5.2%)
Sep 2024
-
$1.34B(-6.4%)
$4.65B(+7.7%)
Jun 2024
-
$1.43B(+98.4%)
$4.32B(+12.0%)
Mar 2024
-
$722.00M(-37.7%)
$3.86B(-2.4%)
Dec 2023
$3.95B(-8.9%)
$1.16B(+15.1%)
$3.95B(-0.9%)
Sep 2023
-
$1.01B(+4.1%)
$3.99B(-7.2%)
Jun 2023
-
$968.40M(+18.4%)
$4.30B(+2.8%)
Mar 2023
-
$817.80M(-31.7%)
$4.18B(-3.6%)
Dec 2022
$4.34B(-46.3%)
$1.20B(-9.0%)
$4.34B(-19.2%)
Sep 2022
-
$1.32B(+54.4%)
$5.37B(-5.6%)
Jun 2022
-
$852.10M(-12.5%)
$5.69B(-28.3%)
Mar 2022
-
$973.50M(-56.3%)
$7.93B(-1.8%)
Dec 2021
$8.08B(+129.9%)
$2.23B(+36.6%)
$8.08B(+15.4%)
Sep 2021
-
$1.63B(-47.3%)
$7.00B(+12.7%)
Jun 2021
-
$3.10B(+177.9%)
$6.21B(+55.0%)
Mar 2021
-
$1.12B(-3.0%)
$4.00B(+14.0%)
Dec 2020
$3.51B(+66.0%)
$1.15B(+36.5%)
$3.51B(+11.3%)
Sep 2020
-
$842.10M(-6.2%)
$3.16B(+5.8%)
Jun 2020
-
$897.30M(+43.7%)
$2.98B(+30.9%)
Mar 2020
-
$624.60M(-21.1%)
$2.28B(+7.7%)
Dec 2019
$2.12B(-13.4%)
$792.00M(+18.3%)
$2.12B(-1.3%)
Sep 2019
-
$669.60M(+246.8%)
$2.14B(+3.6%)
Jun 2019
-
$193.10M(-58.1%)
$2.07B(-14.8%)
Mar 2019
-
$461.10M(-43.8%)
$2.43B(-0.7%)
Dec 2018
$2.44B(+104.0%)
$820.40M(+38.0%)
$2.44B(+36.0%)
Sep 2018
-
$594.65M(+7.8%)
$1.80B(+13.0%)
Jun 2018
-
$551.41M(+15.4%)
$1.59B(+11.5%)
Mar 2018
-
$477.98M(+175.5%)
$1.43B(+19.1%)
Dec 2017
$1.20B(+33.8%)
$173.52M(-55.3%)
$1.20B(-6.2%)
Sep 2017
-
$388.32M(+0.1%)
$1.28B(+10.7%)
Jun 2017
-
$387.74M(+55.8%)
$1.15B(+19.9%)
Mar 2017
-
$248.93M(-1.7%)
$963.07M(+7.5%)
Dec 2016
$895.52M(+40.8%)
$253.12M(-4.4%)
$895.52M(+12.3%)
Sep 2016
-
$264.80M(+35.0%)
$797.40M(+7.3%)
Jun 2016
-
$196.22M(+8.2%)
$743.00M(+0.2%)
Mar 2016
-
$181.38M(+17.0%)
$741.42M(+16.6%)
Dec 2015
$636.06M(+82.7%)
$154.99M(-26.3%)
$636.06M(+7.6%)
Sep 2015
-
$210.40M(+8.1%)
$591.24M(+28.4%)
Jun 2015
-
$194.64M(+156.0%)
$460.56M(+28.4%)
Mar 2015
-
$76.02M(-31.0%)
$358.65M(+3.0%)
Dec 2014
$348.07M(-18.0%)
$110.18M(+38.2%)
$348.07M(+4.0%)
Sep 2014
-
$79.72M(-14.0%)
$334.70M(-15.5%)
Jun 2014
-
$92.73M(+41.7%)
$396.29M(+1.4%)
Mar 2014
-
$65.44M(-32.4%)
$390.93M(-7.9%)
Dec 2013
$424.36M(-43.4%)
$96.81M(-31.5%)
$424.36M(-46.8%)
Sep 2013
-
$141.31M(+61.7%)
$797.96M(-5.9%)
Jun 2013
-
$87.38M(-11.6%)
$848.13M(+1.3%)
Mar 2013
-
$98.87M(-79.0%)
$837.49M(+11.6%)
Dec 2012
$750.27M(+438.3%)
$470.41M(+145.7%)
$750.27M(+231.4%)
Sep 2012
-
$191.47M(+149.5%)
$226.42M(+925.9%)
Jun 2012
-
$76.74M(+558.7%)
-$27.41M(+83.6%)
Mar 2012
-
$11.65M(+121.8%)
-$166.66M(+24.8%)
Dec 2011
-$221.76M(-112.3%)
-$53.44M(+14.3%)
-$221.76M(-21.2%)
Sep 2011
-
-$62.37M(+0.2%)
-$182.91M(-18.4%)
Jun 2011
-
-$62.51M(-43.9%)
-$154.42M(-31.5%)
Mar 2011
-
-$43.45M(-197.6%)
-$117.39M(-12.4%)
Dec 2010
-$104.47M(-54.0%)
-$14.60M(+56.9%)
-$104.47M(+17.3%)
Sep 2010
-
-$33.88M(-33.0%)
-$126.36M(-35.1%)
Jun 2010
-
-$25.47M(+16.5%)
-$93.50M(-12.7%)
Mar 2010
-
-$30.52M(+16.4%)
-$82.96M(-22.3%)
Dec 2009
-$67.83M(+18.0%)
-$36.49M(-3495.0%)
-$67.83M(-7.9%)
Sep 2009
-
-$1.01M(+93.2%)
-$62.86M(+24.2%)
Jun 2009
-
-$14.94M(+2.9%)
-$82.96M(+4.1%)
Mar 2009
-
-$15.39M(+51.2%)
-$86.48M(-4.6%)
Dec 2008
-$82.71M(+21.7%)
-$31.52M(-49.3%)
-$82.71M(-28.7%)
Sep 2008
-
-$21.11M(-14.4%)
-$64.26M(+18.6%)
Jun 2008
-
-$18.46M(-58.9%)
-$78.99M(+9.5%)
Mar 2008
-
-$11.62M(+11.1%)
-$87.30M(+17.3%)
Dec 2007
-$105.60M
-$13.07M(+63.5%)
-$105.60M(+14.5%)
DateAnnualQuarterlyTTM
Sep 2007
-
-$35.84M(-33.9%)
-$123.50M(-7.3%)
Jun 2007
-
-$26.77M(+10.5%)
-$115.07M(-2.9%)
Mar 2007
-
-$29.92M(+3.4%)
-$111.87M(-8.5%)
Dec 2006
-$103.15M(-8.1%)
-$30.97M(-13.0%)
-$103.15M(-1.3%)
Sep 2006
-
-$27.41M(-16.3%)
-$101.85M(+6.6%)
Jun 2006
-
-$23.58M(-11.2%)
-$109.09M(+3.0%)
Mar 2006
-
-$21.19M(+28.6%)
-$112.52M(-17.9%)
Dec 2005
-$95.45M(-328.9%)
-$29.67M(+14.4%)
-$95.45M(-51.5%)
Sep 2005
-
-$34.65M(-28.3%)
-$62.98M(-59.8%)
Jun 2005
-
-$27.00M(-554.8%)
-$39.41M(-46.2%)
Mar 2005
-
-$4.12M(-247.7%)
-$26.96M(-164.6%)
Dec 2004
$41.70M(+138.8%)
$2.79M(+125.2%)
$41.70M(+113.5%)
Sep 2004
-
-$11.08M(+23.9%)
$19.53M(+509.2%)
Jun 2004
-
-$14.55M(-122.5%)
$3.21M(+129.2%)
Mar 2004
-
$64.53M(+433.0%)
-$10.98M(+89.6%)
Dec 2003
-$107.46M(+13.6%)
-$19.38M(+29.3%)
-$105.62M(+13.4%)
Sep 2003
-
-$27.40M(+4.6%)
-$121.94M(+4.3%)
Jun 2003
-
-$28.74M(+4.6%)
-$127.36M(+1.3%)
Mar 2003
-
-$30.11M(+15.6%)
-$129.04M(-3.8%)
Dec 2002
-$124.38M(-63.3%)
-$35.69M(-8.8%)
-$124.38M(-6.2%)
Sep 2002
-
-$32.82M(-7.9%)
-$117.06M(-12.4%)
Jun 2002
-
-$30.42M(-19.6%)
-$104.18M(-17.6%)
Mar 2002
-
-$25.45M(+10.3%)
-$88.59M(-16.3%)
Dec 2001
-$76.18M(-251.8%)
-$28.38M(-42.4%)
-$76.18M(-35.4%)
Sep 2001
-
-$19.93M(-34.4%)
-$56.26M(-42.3%)
Jun 2001
-
-$14.83M(-13.8%)
-$39.54M(-43.0%)
Mar 2001
-
-$13.04M(-54.2%)
-$27.65M(-26.1%)
Dec 2000
-$21.65M(+6.1%)
-$8.46M(-163.3%)
-$21.93M(-47.6%)
Sep 2000
-
-$3.21M(-9.0%)
-$14.86M(+10.3%)
Jun 2000
-
-$2.95M(+59.7%)
-$16.57M(+22.8%)
Mar 2000
-
-$7.32M(-429.5%)
-$21.46M(+7.0%)
Dec 1999
-$23.07M(-167.5%)
-$1.38M(+71.9%)
-$23.07M(+15.3%)
Sep 1999
-
-$4.92M(+37.1%)
-$27.23M(-14.9%)
Jun 1999
-
-$7.83M(+12.3%)
-$23.70M(-72.7%)
Mar 1999
-
-$8.93M(-61.2%)
-$13.73M(-59.1%)
Dec 1998
-$8.63M(+25.5%)
-$5.54M(-297.2%)
-$8.63M(-233.8%)
Sep 1998
-
-$1.40M(-165.2%)
-$2.58M(+16.3%)
Jun 1998
-
$2.14M(+155.9%)
-$3.09M(+67.6%)
Mar 1998
-
-$3.83M(-865.8%)
-$9.53M(+17.9%)
Dec 1997
-$11.58M(+64.3%)
$500.00K(+126.3%)
-$11.60M(+42.6%)
Sep 1997
-
-$1.90M(+55.8%)
-$20.20M(+25.7%)
Jun 1997
-
-$4.30M(+27.1%)
-$27.20M(+10.8%)
Mar 1997
-
-$5.90M(+27.2%)
-$30.50M(+5.9%)
Dec 1996
-$32.42M(-37.9%)
-$8.10M(+9.0%)
-$32.40M(-0.9%)
Sep 1996
-
-$8.90M(-17.1%)
-$32.10M(-5.9%)
Jun 1996
-
-$7.60M(+2.6%)
-$30.30M(-11.8%)
Mar 1996
-
-$7.80M(0.0%)
-$27.10M(-15.3%)
Dec 1995
-$23.51M(+23.3%)
-$7.80M(-9.9%)
-$23.50M(-9.3%)
Sep 1995
-
-$7.10M(-61.4%)
-$21.50M(-16.8%)
Jun 1995
-
-$4.40M(-4.8%)
-$18.40M(+24.0%)
Mar 1995
-
-$4.20M(+27.6%)
-$24.20M(+21.2%)
Dec 1994
-$30.65M(+23.1%)
-$5.80M(-45.0%)
-$30.70M(+15.7%)
Sep 1994
-
-$4.00M(+60.8%)
-$36.40M(+13.3%)
Jun 1994
-
-$10.20M(+4.7%)
-$42.00M(-1.9%)
Mar 1994
-
-$10.70M(+7.0%)
-$41.20M(-3.5%)
Dec 1993
-$39.88M(-108.7%)
-$11.50M(-19.8%)
-$39.80M(-14.7%)
Sep 1993
-
-$9.60M(-2.1%)
-$34.70M(-12.3%)
Jun 1993
-
-$9.40M(-1.1%)
-$30.90M(-22.6%)
Mar 1993
-
-$9.30M(-45.3%)
-$25.20M(-31.3%)
Dec 1992
-$19.11M(-327.8%)
-$6.40M(-10.3%)
-$19.20M(-28.9%)
Sep 1992
-
-$5.80M(-56.8%)
-$14.90M(-49.0%)
Jun 1992
-
-$3.70M(-12.1%)
-$10.00M(-51.5%)
Mar 1992
-
-$3.30M(-57.1%)
-$6.60M(-50.0%)
Dec 1991
-$4.47M(-35.4%)
-$2.10M(-133.3%)
-$4.40M(-37.5%)
Sep 1991
-
-$900.00K(-200.0%)
-$3.20M(-3.2%)
Jun 1991
-
-$300.00K(+72.7%)
-$3.10M(+13.9%)
Mar 1991
-
-$1.10M(-22.2%)
-$3.60M(-9.1%)
Dec 1990
-$3.30M
-$900.00K(-12.5%)
-$3.30M(-37.5%)
Sep 1990
-
-$800.00K(0.0%)
-$2.40M(-50.0%)
Jun 1990
-
-$800.00K(0.0%)
-$1.60M(-100.0%)
Mar 1990
-
-$800.00K
-$800.00K

FAQ

  • What is Regeneron Pharmaceuticals, Inc. annual net profit?
  • What is the all-time high annual net income for Regeneron Pharmaceuticals, Inc.?
  • What is Regeneron Pharmaceuticals, Inc. annual net income year-on-year change?
  • What is Regeneron Pharmaceuticals, Inc. quarterly net profit?
  • What is the all-time high quarterly net income for Regeneron Pharmaceuticals, Inc.?
  • What is Regeneron Pharmaceuticals, Inc. quarterly net income year-on-year change?
  • What is Regeneron Pharmaceuticals, Inc. TTM net profit?
  • What is the all-time high TTM net income for Regeneron Pharmaceuticals, Inc.?
  • What is Regeneron Pharmaceuticals, Inc. TTM net income year-on-year change?

What is Regeneron Pharmaceuticals, Inc. annual net profit?

The current annual net income of REGN is $4.41B

What is the all-time high annual net income for Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. all-time high annual net profit is $8.08B

What is Regeneron Pharmaceuticals, Inc. annual net income year-on-year change?

Over the past year, REGN annual net profit has changed by +$459.00M (+11.61%)

What is Regeneron Pharmaceuticals, Inc. quarterly net profit?

The current quarterly net income of REGN is $1.39B

What is the all-time high quarterly net income for Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. all-time high quarterly net profit is $3.10B

What is Regeneron Pharmaceuticals, Inc. quarterly net income year-on-year change?

Over the past year, REGN quarterly net profit has changed by -$40.70M (-2.84%)

What is Regeneron Pharmaceuticals, Inc. TTM net profit?

The current TTM net income of REGN is $4.46B

What is the all-time high TTM net income for Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. all-time high TTM net profit is $8.08B

What is Regeneron Pharmaceuticals, Inc. TTM net income year-on-year change?

Over the past year, REGN TTM net profit has changed by +$136.90M (+3.17%)
On this page